These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4004197)

  • 1. Once-daily ceftriaxone for skin and soft tissue infections.
    Gordin FM; Wofsy CB; Mills J
    Antimicrob Agents Chemother; 1985 Apr; 27(4):648-9. PubMed ID: 4004197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone for once-a-day therapy of urinary tract infections.
    Childs SJ; Wells WG; Mirelman S
    Am J Med; 1984 Oct; 77(4C):73-6. PubMed ID: 6093524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings.
    Eron LJ; Park CH; Hixon DL; Goldenberg RI; Poretz DM
    Antimicrob Agents Chemother; 1983 May; 23(5):731-7. PubMed ID: 6307135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone therapy of serious bacterial infections in adults.
    Bittner MJ; Dworzack DL; Preheim LC; Tofte RW; Crossley KB
    Antimicrob Agents Chemother; 1983 Feb; 23(2):261-6. PubMed ID: 6301365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose antimicrobial prophylaxis in open heart surgery.
    Beam T; Raab T; Spooner J; Balderman S; Aldridge J; Bhayana J
    Eur J Clin Microbiol; 1984 Dec; 3(6):598-604. PubMed ID: 6098476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily cefazolin and probenecid for skin and soft tissue infections.
    Cox VC; Zed PJ
    Ann Pharmacother; 2004 Mar; 38(3):458-63. PubMed ID: 14970368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone therapy of serious bacterial infections.
    Eron LJ; Park CH; Goldenberg RI; Poretz DM
    J Antimicrob Chemother; 1983 Jul; 12(1):65-78. PubMed ID: 6311783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of ceftriaxone in the pediatric field].
    Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
    Jpn J Antibiot; 1984 Nov; 37(11):2027-33. PubMed ID: 6098699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.
    Maslow MJ; Levine JF; Pollock AA; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1982 Jul; 22(1):103-7. PubMed ID: 6289735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
    Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
    J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of comparative clinical studies of ceftizoxime and cefamandole, cefazolin and tobramycin.
    Duma RJ
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():303-9. PubMed ID: 6296025
    [No Abstract]   [Full Text] [Related]  

  • 13. Ceftriaxone or cefazolin prophylaxis for the prevention of infection after vaginal hysterectomy.
    Hemsell DL; Menon MO; Friedman AJ
    Am J Surg; 1984 Oct; 148(4A):22-6. PubMed ID: 6091476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV
    Am J Med; 1984 Oct; 77(4C):97-103. PubMed ID: 6093528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ceftriaxone and cefazolin prophylaxis against infection in open heart surgery.
    Beam TR; Raab TA; Spooner JA; Balderman SC; Aldridge J; Bahyana JN
    Am J Surg; 1984 Oct; 148(4A):8-14. PubMed ID: 6091484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone versus cefazolin with probenecid for severe skin and soft tissue infections.
    Brown G; Chamberlain R; Goulding J; Clarke A
    J Emerg Med; 1996; 14(5):547-51. PubMed ID: 8933313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults.
    Grayson ML; McDonald M; Gibson K; Athan E; Munckhof WJ; Paull P; Chambers F
    Clin Infect Dis; 2002 Jun; 34(11):1440-8. PubMed ID: 12015689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotic prophylaxis in abdominal surgery. Prospective randomized study organized by the French Surgical Research Association].
    Rotman N; Flamant Y; Hay JM; Fagniez PL
    Presse Med; 1991 Oct; 20(34):1659-63. PubMed ID: 1836569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic prophylaxis in high-risk biliary operations: multicenter trial of single preoperative ceftriaxone versus multidose cefazolin.
    Kellum JM; Gargano S; Gorbach SL; Talcof C; Curtis LE; Weiner B; McCoobery M; Tan JS; Kelly T; Wagner D
    Am J Surg; 1984 Oct; 148(4A):15-8. PubMed ID: 6091474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefotaxime treatment of skin and skin structure infections: a multicenter study.
    LeFrock JL; McCloskey RV
    Clin Ther; 1982; 5 Suppl A():19-25. PubMed ID: 6293714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.